This has the advantage of specifically labeling iNOS, but levels of iNOS in leukocytes is low on a whole-organism setting, and the wholemount antibody staining requires amplification using TSA therefore reducing the potential to accurately quantify the amount of iNOS produced, although an increase was observed after Mm infection (figure 1B and E). This evidence concerns the gene NOS2 and infection.